Tennessee Senate Bill SB0550

Tennessee 2025-2026 Regular Session

• Introduced: 1/30/25
• Engrossed: 3/23/26
• Enrolled: 4/15/26
• Passed: 4/27/26
• Chaptered: 5/5/26

Caption

AN ACT to amend Tennessee Code Annotated, Title 4 and Title 68, Chapter 7, relative to the medical cannabis commission.

Summary

SB0550 amends Tennessee law governing the medical cannabis commission by increasing the commission’s membership from nine to ten members. It revises the governor’s appointment authority to require four gubernatorial appointees and specifies the qualifications for those appointees, including a patient with a qualifying medical condition or a caregiver for such a patient, a subject matter expert in cannabis cultivation/processing/distribution/prescribing for medical use, another member who meets either of those qualifications, and a nonvoting specialist in substance abuse prevention. The bill also updates the statutory structure in Title 68, Chapter 7, which governs the medical cannabis commission, and makes the changes effective July 1, 2026, applying only to appointments made on or after that date. In practical terms, it changes who may serve on the commission and adds a nonvoting public health-oriented role, while leaving the commission’s core purpose intact.

Impact

The bill directly amends Tennessee Code Annotated, Section 68-7-103, by expanding the commission from nine to ten members and redefining the composition of gubernatorial appointments. It affects the appointment process for the medical cannabis commission and may influence future policy development, oversight, and implementation of Tennessee’s medical cannabis framework by ensuring representation from patients, caregivers, cannabis industry or clinical expertise, and substance abuse prevention.

Sentiment

The available voting history shows strong, unanimous support at each stage: the Senate Judiciary Committee recommended passage 9-0, the Senate floor passed the amended bill 31-0, and the House passed it 92-0. The absence of recorded opposition suggests broad bipartisan agreement or at least no visible organized resistance to the commission membership changes.

Contention

No committee transcript is available, and the recorded votes show no dissent, so there is little evidence of active controversy in the legislative record provided. The only potentially sensitive policy issue is the inclusion of a medical cannabis subject matter expert and a patient/caregiver representative on a state commission, along with a nonvoting substance abuse prevention specialist, but the bill’s unanimous passage indicates these provisions were not materially contentious among lawmakers.